Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

No longer available × veliparib × Breast × Clear all

Status

Completed 17 No longer available 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2

Interventions

veliparib 2 tucatinib 1 pegilodecakin 1 palbociclib 1 iniparib 1 glembatumumab vedotin 1 Vinorelbine 1 Letrozole 1 Everolimus 1 Cisplatin 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03123211 2022-05-24

Expanded Access to Veliparib

AbbVie

No longer available

Triple Negative Breast Neoplasms

NCT02985658 2021-07-21

Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer

University of Washington

No longer available

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡